Becton, Dickinson and Company Stock
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207.42 USD | +2.93% |
|
+2.32% | +6.88% |
| Capitalization | 59.1B 50.71B 47.22B 43.94B 81.99B 5,335B 88.39B 543B 214B 2,552B 222B 217B 9,351B | P/E ratio 2026 * |
31x | P/E ratio 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise value | 74.8B 64.19B 59.77B 55.62B 104B 6,753B 112B 687B 270B 3,230B 281B 275B 11,837B | EV / Sales 2026 * |
3.32x | EV / Sales 2027 * | 3.11x |
| Free-Float |
77.04% | Yield 2026 * |
1.98% | Yield 2027 * | 2.03% |
Last Transcript: Becton, Dickinson and Company
| 1 day | +2.93% | ||
| 1 week | +2.32% | ||
| Current month | +6.88% | ||
| 1 month | +3.25% | ||
| 3 months | +10.12% | ||
| 6 months | +17.13% | ||
| Current year | +6.88% |
| 1 week | 198.44 |  | 207.64 |
| 1 month | 192.48 | | 207.64 |
| Current year | 192.48 | | 207.64 |
| 1 year | 162.29 | | 251.98 |
| 3 years | 162.29 | | 287.32 |
| 5 years | 162.29 | | 287.32 |
| 10 years | 129.5 | | 287.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 53 | 2020-01-27 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 56 | 2023-12-03 |
Claudia Curtis
CMP | Compliance Officer | - | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 75 | 2002-09-23 |
| Director/Board Member | 71 | 2006-11-19 | |
| Director/Board Member | 71 | 2010-07-25 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.64% | 15.4% | 303 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.93% | +2.32% | -12.04% | -18.93% | 59.1B | |
| +0.56% | -1.61% | +10.60% | +10.12% | 217B | |
| +2.41% | -1.03% | +15.82% | +22.52% | 127B | |
| +1.17% | +2.80% | +45.77% | +113.01% | 67.88B | |
| -1.41% | +2.24% | +26.03% | +95.35% | 55.55B | |
| +1.31% | +7.37% | - | - | 36.13B | |
| -0.78% | -0.57% | -11.96% | -35.74% | 27.18B | |
| +1.69% | +1.95% | +27.31% | +30.80% | 25.94B | |
| +0.72% | -4.26% | +5.18% | -34.60% | 23.78B | |
| -1.67% | -1.82% | -24.76% | +26.59% | 21.24B | |
| Average | +0.70% | +0.90% | +9.11% | +23.23% | 66.07B | |
| Weighted average by Cap. | +0.99% | +0.31% | +13.02% | +26.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.52B 19.32B 17.99B 16.74B 31.25B 2,033B 33.68B 207B 81.38B 973B 84.46B 82.72B 3,564B | 23.31B 20B 18.62B 17.33B 32.34B 2,104B 34.86B 214B 84.23B 1,007B 87.41B 85.61B 3,688B |
| Net income | 2.02B 1.73B 1.61B 1.5B 2.8B 182B 3.02B 18.57B 7.3B 87.29B 7.58B 7.42B 320B | 2.38B 2.04B 1.9B 1.77B 3.3B 215B 3.56B 21.86B 8.6B 103B 8.92B 8.74B 377B |
| Net Debt | 15.71B 13.48B 12.55B 11.68B 21.8B 1,418B 23.5B 144B 56.77B 678B 58.92B 57.7B 2,486B | 13.36B 11.46B 10.67B 9.93B 18.53B 1,206B 19.98B 123B 48.27B 577B 50.09B 49.06B 2,114B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-14 | 207.42 $ | +2.93% | 1,442,810 |
| 26-01-13 | 201.52 $ | -0.60% | 1,158,393 |
| 26-01-12 | 202.74 $ | -0.00% | 1,381,370 |
| 26-01-09 | 202.75 $ | -1.18% | 1,321,253 |
| 26-01-08 | 205.18 $ | +1.22% | 1,430,092 |
Delayed Quote Nyse, January 14, 2026 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BDX Stock
Select your edition
All financial news and data tailored to specific country editions
